Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Recombinant Coagulation Factor VIII for Injection

Approval Number

国药准字SJ20210021

CompanyGC Biopharma Corp.

Registration Date

August 5, 2021

Drug Information

Generic Name

注射用重组人凝血因子Ⅷ

Trade Name

绿茵芷

Dosage Form

注射剂

Strength

500IU/瓶

Drug Type

生物制品

Registration Date

August 5, 2021

Expiry Date

August 4, 2026

Company Information

Applicant Company

Company NameGC Biopharma Corp.

Company Address

586, Gwahaksaneop 2-ro, Ochang-eup, Cheongwon-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea

Manufacturing Company

Company NameGC Biopharma Corp.

Company Address

586, Gwahaksaneop 2-ro, Ochang-eup, Cheongwon-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy